 | • レポートコード：GIR-107A12011 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、βアドレナリン受容体作動薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。βアドレナリン受容体作動薬の種類別市場規模（イソプレナリン、ドブタミン、サルブタモール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール）、用途別市場規模（慢性心不全、心筋梗塞、術後低血圧、気管支喘息、喘息性気管支炎、肺気腫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・βアドレナリン受容体作動薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Ivax Pharmaceuticals 、Physicians Total Care、Baxter Healthcare 、Sanofi、Pfizer、Bedford Laboratories、Novartis、Sterimax、Teligent、AstraZeneca、Hikma Pharmaceuticals、Av Kare、Impax Laboratories、PD-Rx Pharmaceuticals、Athenex Pharmaceutical Division、Teva、Marlex Pharmaceuticals、Lannett Company、West-Ward Pharmaceuticals、United Biomedical、Merck、Mylan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：イソプレナリン、ドブタミン、サルブタモール、テルブタリン、サルメテロール、ホルモテロール、ピルブテロール ・用途別分析2016年-2026年：慢性心不全、心筋梗塞、術後低血圧、気管支喘息、喘息性気管支炎、肺気腫、その他 ・βアドレナリン受容体作動薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・βアドレナリン受容体作動薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・βアドレナリン受容体作動薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・βアドレナリン受容体作動薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・βアドレナリン受容体作動薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The β Adrenoceptor Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global β Adrenoceptor Agonists size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global β Adrenoceptor Agonists market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
β Adrenoceptor Agonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Isoprenaline
Dobutamine
Salbutamol
Terbutaline
Salmeterol
Formoterol
Pirbuterol
Market segment by Application, can be divided into
Chronic Heart Failure
Myocardial Infarction
Postoperative Hypotension
Bronchial Asthma
Asthmatic Bronchitis
Emphysema
Others
Market segment by players, this report covers
Ivax Pharmaceuticals
Physicians Total Care
Baxter Healthcare
Sanofi
Pfizer
Bedford Laboratories
Novartis
Sterimax
Teligent
AstraZeneca
Hikma Pharmaceuticals
Av Kare
Impax Laboratories
PD-Rx Pharmaceuticals
Athenex Pharmaceutical Division
Teva
Marlex Pharmaceuticals
Lannett Company
West-Ward Pharmaceuticals
United Biomedical
Merck
Mylan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of β Adrenoceptor Agonists
1.2 Classification of β Adrenoceptor Agonists by Type
1.2.1 Overview: Global β Adrenoceptor Agonists Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global β Adrenoceptor Agonists Revenue Market Share by Type in 2020
1.2.3 Isoprenaline
1.2.4 Dobutamine
1.2.5 Salbutamol
1.2.6 Terbutaline
1.2.7 Salmeterol
1.2.8 Formoterol
1.2.9 Pirbuterol
1.3 Global β Adrenoceptor Agonists Market by Application
1.3.1 Overview: Global β Adrenoceptor Agonists Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Chronic Heart Failure
1.3.3 Myocardial Infarction
1.3.4 Postoperative Hypotension
1.3.5 Bronchial Asthma
1.3.6 Asthmatic Bronchitis
1.3.7 Emphysema
1.3.8 Others
1.4 Global β Adrenoceptor Agonists Market Size & Forecast
1.5 Global β Adrenoceptor Agonists Market Size and Forecast by Region
1.5.1 Global β Adrenoceptor Agonists Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global β Adrenoceptor Agonists Market Size by Region, (2016-2021)
1.5.3 North America β Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.4 Europe β Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific β Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.6 South America β Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa β Adrenoceptor Agonists Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 β Adrenoceptor Agonists Market Drivers
1.6.2 β Adrenoceptor Agonists Market Restraints
1.6.3 β Adrenoceptor Agonists Trends Analysis
2 Company Profiles
2.1 Ivax Pharmaceuticals
2.1.1 Ivax Pharmaceuticals Details
2.1.2 Ivax Pharmaceuticals Major Business
2.1.3 Ivax Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
2.1.4 Ivax Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Ivax Pharmaceuticals Recent Developments and Future Plans
2.2 Physicians Total Care
2.2.1 Physicians Total Care Details
2.2.2 Physicians Total Care Major Business
2.2.3 Physicians Total Care β Adrenoceptor Agonists Product and Solutions
2.2.4 Physicians Total Care β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Physicians Total Care Recent Developments and Future Plans
2.3 Baxter Healthcare
2.3.1 Baxter Healthcare Details
2.3.2 Baxter Healthcare Major Business
2.3.3 Baxter Healthcare β Adrenoceptor Agonists Product and Solutions
2.3.4 Baxter Healthcare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Baxter Healthcare Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi β Adrenoceptor Agonists Product and Solutions
2.4.4 Sanofi β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer β Adrenoceptor Agonists Product and Solutions
2.5.4 Pfizer β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfizer Recent Developments and Future Plans
2.6 Bedford Laboratories
2.6.1 Bedford Laboratories Details
2.6.2 Bedford Laboratories Major Business
2.6.3 Bedford Laboratories β Adrenoceptor Agonists Product and Solutions
2.6.4 Bedford Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bedford Laboratories Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis β Adrenoceptor Agonists Product and Solutions
2.7.4 Novartis β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Sterimax
2.8.1 Sterimax Details
2.8.2 Sterimax Major Business
2.8.3 Sterimax β Adrenoceptor Agonists Product and Solutions
2.8.4 Sterimax β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sterimax Recent Developments and Future Plans
2.9 Teligent
2.9.1 Teligent Details
2.9.2 Teligent Major Business
2.9.3 Teligent β Adrenoceptor Agonists Product and Solutions
2.9.4 Teligent β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Teligent Recent Developments and Future Plans
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca β Adrenoceptor Agonists Product and Solutions
2.10.4 AstraZeneca β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 AstraZeneca Recent Developments and Future Plans
2.11 Hikma Pharmaceuticals
2.11.1 Hikma Pharmaceuticals Details
2.11.2 Hikma Pharmaceuticals Major Business
2.11.3 Hikma Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
2.11.4 Hikma Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.12 Av Kare
2.12.1 Av Kare Details
2.12.2 Av Kare Major Business
2.12.3 Av Kare β Adrenoceptor Agonists Product and Solutions
2.12.4 Av Kare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Av Kare Recent Developments and Future Plans
2.13 Impax Laboratories
2.13.1 Impax Laboratories Details
2.13.2 Impax Laboratories Major Business
2.13.3 Impax Laboratories β Adrenoceptor Agonists Product and Solutions
2.13.4 Impax Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Impax Laboratories Recent Developments and Future Plans
2.14 PD-Rx Pharmaceuticals
2.14.1 PD-Rx Pharmaceuticals Details
2.14.2 PD-Rx Pharmaceuticals Major Business
2.14.3 PD-Rx Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
2.14.4 PD-Rx Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 PD-Rx Pharmaceuticals Recent Developments and Future Plans
2.15 Athenex Pharmaceutical Division
2.15.1 Athenex Pharmaceutical Division Details
2.15.2 Athenex Pharmaceutical Division Major Business
2.15.3 Athenex Pharmaceutical Division β Adrenoceptor Agonists Product and Solutions
2.15.4 Athenex Pharmaceutical Division β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Athenex Pharmaceutical Division Recent Developments and Future Plans
2.16 Teva
2.16.1 Teva Details
2.16.2 Teva Major Business
2.16.3 Teva β Adrenoceptor Agonists Product and Solutions
2.16.4 Teva β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Teva Recent Developments and Future Plans
2.17 Marlex Pharmaceuticals
2.17.1 Marlex Pharmaceuticals Details
2.17.2 Marlex Pharmaceuticals Major Business
2.17.3 Marlex Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
2.17.4 Marlex Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Marlex Pharmaceuticals Recent Developments and Future Plans
2.18 Lannett Company
2.18.1 Lannett Company Details
2.18.2 Lannett Company Major Business
2.18.3 Lannett Company β Adrenoceptor Agonists Product and Solutions
2.18.4 Lannett Company β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Lannett Company Recent Developments and Future Plans
2.19 West-Ward Pharmaceuticals
2.19.1 West-Ward Pharmaceuticals Details
2.19.2 West-Ward Pharmaceuticals Major Business
2.19.3 West-Ward Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
2.19.4 West-Ward Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 West-Ward Pharmaceuticals Recent Developments and Future Plans
2.20 United Biomedical
2.20.1 United Biomedical Details
2.20.2 United Biomedical Major Business
2.20.3 United Biomedical β Adrenoceptor Agonists Product and Solutions
2.20.4 United Biomedical β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 United Biomedical Recent Developments and Future Plans
2.21 Merck
2.21.1 Merck Details
2.21.2 Merck Major Business
2.21.3 Merck β Adrenoceptor Agonists Product and Solutions
2.21.4 Merck β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Merck Recent Developments and Future Plans
2.22 Mylan
2.22.1 Mylan Details
2.22.2 Mylan Major Business
2.22.3 Mylan β Adrenoceptor Agonists Product and Solutions
2.22.4 Mylan β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Mylan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global β Adrenoceptor Agonists Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 β Adrenoceptor Agonists Players Market Share
3.2.2 Top 10 β Adrenoceptor Agonists Players Market Share
3.2.3 Market Competition Trend
3.3 β Adrenoceptor Agonists Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global β Adrenoceptor Agonists Revenue and Market Share by Type (2016-2021)
4.2 Global β Adrenoceptor Agonists Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global β Adrenoceptor Agonists Revenue Market Share by Application (2016-2021)
5.2 β Adrenoceptor Agonists Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America β Adrenoceptor Agonists Revenue by Type (2016-2026)
6.2 North America β Adrenoceptor Agonists Revenue by Application (2016-2026)
6.3 North America β Adrenoceptor Agonists Market Size by Country
6.3.1 North America β Adrenoceptor Agonists Revenue by Country (2016-2026)
6.3.2 United States β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
6.3.3 Canada β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
6.3.4 Mexico β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe β Adrenoceptor Agonists Revenue by Type (2016-2026)
7.2 Europe β Adrenoceptor Agonists Revenue by Application (2016-2026)
7.3 Europe β Adrenoceptor Agonists Market Size by Country
7.3.1 Europe β Adrenoceptor Agonists Revenue by Country (2016-2026)
7.3.2 Germany β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.3 France β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.4 United Kingdom β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.5 Russia β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
7.3.6 Italy β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific β Adrenoceptor Agonists Revenue by Type (2016-2026)
8.2 Asia-Pacific β Adrenoceptor Agonists Revenue by Application (2016-2026)
8.3 Asia-Pacific β Adrenoceptor Agonists Market Size by Region
8.3.1 Asia-Pacific β Adrenoceptor Agonists Revenue by Region (2016-2026)
8.3.2 China β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.3 Japan β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.4 South Korea β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.5 India β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
8.3.7 Australia β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America β Adrenoceptor Agonists Revenue by Type (2016-2026)
9.2 South America β Adrenoceptor Agonists Revenue by Application (2016-2026)
9.3 South America β Adrenoceptor Agonists Market Size by Country
9.3.1 South America β Adrenoceptor Agonists Revenue by Country (2016-2026)
9.3.2 Brazil β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
9.3.3 Argentina β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa β Adrenoceptor Agonists Revenue by Type (2016-2026)
10.2 Middle East & Africa β Adrenoceptor Agonists Revenue by Application (2016-2026)
10.3 Middle East & Africa β Adrenoceptor Agonists Market Size by Country
10.3.1 Middle East & Africa β Adrenoceptor Agonists Revenue by Country (2016-2026)
10.3.2 Turkey β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
10.3.4 UAE β Adrenoceptor Agonists Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global β Adrenoceptor Agonists Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global β Adrenoceptor Agonists Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market β Adrenoceptor Agonists Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global β Adrenoceptor Agonists Revenue (USD Million) by Region (2016-2021)
Table 5. Global β Adrenoceptor Agonists Revenue Market Share by Region (2021-2026)
Table 6. Ivax Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Ivax Pharmaceuticals Major Business
Table 8. Ivax Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
Table 9. Ivax Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Physicians Total Care Corporate Information, Head Office, and Major Competitors
Table 11. Physicians Total Care Major Business
Table 12. Physicians Total Care β Adrenoceptor Agonists Product and Solutions
Table 13. Physicians Total Care β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Baxter Healthcare Corporate Information, Head Office, and Major Competitors
Table 15. Baxter Healthcare Major Business
Table 16. Baxter Healthcare β Adrenoceptor Agonists Product and Solutions
Table 17. Baxter Healthcare β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi β Adrenoceptor Agonists Product and Solutions
Table 21. Sanofi β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfizer Corporate Information, Head Office, and Major Competitors
Table 23. Pfizer Major Business
Table 24. Pfizer β Adrenoceptor Agonists Product and Solutions
Table 25. Pfizer β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bedford Laboratories Corporate Information, Head Office, and Major Competitors
Table 27. Bedford Laboratories Major Business
Table 28. Bedford Laboratories β Adrenoceptor Agonists Product and Solutions
Table 29. Bedford Laboratories β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis β Adrenoceptor Agonists Product and Solutions
Table 33. Novartis β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sterimax Corporate Information, Head Office, and Major Competitors
Table 35. Sterimax Major Business
Table 36. Sterimax β Adrenoceptor Agonists Product and Solutions
Table 37. Sterimax β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Teligent Corporate Information, Head Office, and Major Competitors
Table 39. Teligent Major Business
Table 40. Teligent β Adrenoceptor Agonists Product and Solutions
Table 41. Teligent β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 43. AstraZeneca Major Business
Table 44. AstraZeneca β Adrenoceptor Agonists Product and Solutions
Table 45. AstraZeneca β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 47. Hikma Pharmaceuticals Major Business
Table 48. Hikma Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
Table 49. Hikma Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Av Kare Corporate Information, Head Office, and Major Competitors
Table 51. Av Kare Major Business
Table 52. Av Kare β Adrenoceptor Agonists Product and Solutions
Table 53. Av Kare β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Impax Laboratories Corporate Information, Head Office, and Major Competitors
Table 55. Impax Laboratories Major Business
Table 56. Impax Laboratories β Adrenoceptor Agonists Product and Solutions
Table 57. Impax Laboratories β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. PD-Rx Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. PD-Rx Pharmaceuticals Major Business
Table 60. PD-Rx Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
Table 61. PD-Rx Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Athenex Pharmaceutical Division Corporate Information, Head Office, and Major Competitors
Table 63. Athenex Pharmaceutical Division Major Business
Table 64. Athenex Pharmaceutical Division β Adrenoceptor Agonists Product and Solutions
Table 65. Athenex Pharmaceutical Division β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Teva Corporate Information, Head Office, and Major Competitors
Table 67. Teva Major Business
Table 68. Teva β Adrenoceptor Agonists Product and Solutions
Table 69. Teva β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Marlex Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 71. Marlex Pharmaceuticals Major Business
Table 72. Marlex Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
Table 73. Marlex Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Lannett Company Corporate Information, Head Office, and Major Competitors
Table 75. Lannett Company Major Business
Table 76. Lannett Company β Adrenoceptor Agonists Product and Solutions
Table 77. Lannett Company β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. West-Ward Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 79. West-Ward Pharmaceuticals Major Business
Table 80. West-Ward Pharmaceuticals β Adrenoceptor Agonists Product and Solutions
Table 81. West-Ward Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. United Biomedical Corporate Information, Head Office, and Major Competitors
Table 83. United Biomedical Major Business
Table 84. United Biomedical β Adrenoceptor Agonists Product and Solutions
Table 85. United Biomedical β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Merck Corporate Information, Head Office, and Major Competitors
Table 87. Merck Major Business
Table 88. Merck β Adrenoceptor Agonists Product and Solutions
Table 89. Merck β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Mylan Corporate Information, Head Office, and Major Competitors
Table 91. Mylan Major Business
Table 92. Mylan β Adrenoceptor Agonists Product and Solutions
Table 93. Mylan β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Global β Adrenoceptor Agonists Revenue (USD Million) by Players (2019-2021)
Table 95. Global β Adrenoceptor Agonists Revenue Share by Players (2019-2021)
Table 96. Breakdown of β Adrenoceptor Agonists by Company Type (Tier 1, Tier 2 and Tier 3)
Table 97. β Adrenoceptor Agonists Players Head Office, Products and Services Provided
Table 98. β Adrenoceptor Agonists Mergers & Acquisitions in the Past Five Years
Table 99. β Adrenoceptor Agonists New Entrants and Expansion Plans
Table 100. Global β Adrenoceptor Agonists Revenue (USD Million) by Type (2016-2021)
Table 101. Global β Adrenoceptor Agonists Revenue Share by Type (2016-2021)
Table 102. Global β Adrenoceptor Agonists Revenue Forecast by Type (2021-2026)
Table 103. Global β Adrenoceptor Agonists Revenue by Application (2016-2021)
Table 104. Global β Adrenoceptor Agonists Revenue Forecast by Application (2021-2026)
Table 105. North America β Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 106. North America β Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 107. North America β Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 108. North America β Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 109. North America β Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 110. North America β Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
Table 111. Europe β Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 112. Europe β Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 113. Europe β Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 114. Europe β Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 115. Europe β Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 116. Europe β Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
Table 117. Asia-Pacific β Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 118. Asia-Pacific β Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 119. Asia-Pacific β Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 120. Asia-Pacific β Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 121. Asia-Pacific β Adrenoceptor Agonists Revenue by Region (2016-2021) & (USD Million)
Table 122. Asia-Pacific β Adrenoceptor Agonists Revenue by Region (2021-2026) & (USD Million)
Table 123. South America β Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 124. South America β Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 125. South America β Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 126. South America β Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 127. South America β Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 128. South America β Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
Table 129. Middle East & Africa β Adrenoceptor Agonists Revenue by Type (2016-2021) & (USD Million)
Table 130. Middle East & Africa β Adrenoceptor Agonists Revenue by Type (2021-2026) & (USD Million)
Table 131. Middle East & Africa β Adrenoceptor Agonists Revenue by Application (2016-2021) & (USD Million)
Table 132. Middle East & Africa β Adrenoceptor Agonists Revenue by Application (2021-2026) & (USD Million)
Table 133. Middle East & Africa β Adrenoceptor Agonists Revenue by Country (2016-2021) & (USD Million)
Table 134. Middle East & Africa β Adrenoceptor Agonists Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. β Adrenoceptor Agonists Picture
Figure 2. Global β Adrenoceptor Agonists Revenue Market Share by Type in 2020
Figure 3. Isoprenaline
Figure 4. Dobutamine
Figure 5. Salbutamol
Figure 6. Terbutaline
Figure 7. Salmeterol
Figure 8. Formoterol
Figure 9. Pirbuterol
Figure 10. β Adrenoceptor Agonists Revenue Market Share by Application in 2020
Figure 11. Chronic Heart Failure Picture
Figure 12. Myocardial Infarction Picture
Figure 13. Postoperative Hypotension Picture
Figure 14. Bronchial Asthma Picture
Figure 15. Asthmatic Bronchitis Picture
Figure 16. Emphysema Picture
Figure 17. Others Picture
Figure 18. Global β Adrenoceptor Agonists Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 19. Global β Adrenoceptor Agonists Revenue and Forecast (2016-2026) & (USD Million)
Figure 20. Global β Adrenoceptor Agonists Revenue Market Share by Region (2016-2026)
Figure 21. Global β Adrenoceptor Agonists Revenue Market Share by Region in 2020
Figure 22. North America β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. Europe β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Asia-Pacific β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. South America β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 26. Middle East and Africa β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2016-2026)
Figure 27. β Adrenoceptor Agonists Market Drivers
Figure 28. β Adrenoceptor Agonists Market Restraints
Figure 29. β Adrenoceptor Agonists Market Trends
Figure 30. Ivax Pharmaceuticals Recent Developments and Future Plans
Figure 31. Physicians Total Care Recent Developments and Future Plans
Figure 32. Baxter Healthcare Recent Developments and Future Plans
Figure 33. Sanofi Recent Developments and Future Plans
Figure 34. Pfizer Recent Developments and Future Plans
Figure 35. Bedford Laboratories Recent Developments and Future Plans
Figure 36. Novartis Recent Developments and Future Plans
Figure 37. Sterimax Recent Developments and Future Plans
Figure 38. Teligent Recent Developments and Future Plans
Figure 39. AstraZeneca Recent Developments and Future Plans
Figure 40. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 41. Av Kare Recent Developments and Future Plans
Figure 42. Impax Laboratories Recent Developments and Future Plans
Figure 43. PD-Rx Pharmaceuticals Recent Developments and Future Plans
Figure 44. Athenex Pharmaceutical Division Recent Developments and Future Plans
Figure 45. Teva Recent Developments and Future Plans
Figure 46. Marlex Pharmaceuticals Recent Developments and Future Plans
Figure 47. Lannett Company Recent Developments and Future Plans
Figure 48. West-Ward Pharmaceuticals Recent Developments and Future Plans
Figure 49. United Biomedical Recent Developments and Future Plans
Figure 50. Merck Recent Developments and Future Plans
Figure 51. Mylan Recent Developments and Future Plans
Figure 52. Global β Adrenoceptor Agonists Revenue Share by Players in 2020
Figure 53. β Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 54. Global Top 3 Players β Adrenoceptor Agonists Revenue Market Share in 2020
Figure 55. Global Top 10 Players β Adrenoceptor Agonists Revenue Market Share in 2020
Figure 56. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 57. Global β Adrenoceptor Agonists Revenue Share by Type in 2020
Figure 58. Global β Adrenoceptor Agonists Market Share Forecast by Type (2021-2026)
Figure 59. Global β Adrenoceptor Agonists Revenue Share by Application in 2020
Figure 60. Global β Adrenoceptor Agonists Market Share Forecast by Application (2021-2026)
Figure 61. North America β Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 62. North America β Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 63. North America β Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 64. United States β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Canada β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Mexico β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Europe β Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 68. Europe β Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 69. Europe β Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 70. Germany β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. France β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. United Kingdom β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Russia β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Italy β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Asia-Pacific β Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 76. Asia-Pacific β Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 77. Asia-Pacific β Adrenoceptor Agonists Revenue Market Share by Region (2016-2026)
Figure 78. China β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Japan β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. South Korea β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. India β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Southeast Asia β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Australia β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. South America β Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 85. South America β Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 86. South America β Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 87. Brazil β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Argentina β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. Middle East and Africa β Adrenoceptor Agonists Sales Market Share by Type (2016-2026)
Figure 90. Middle East and Africa β Adrenoceptor Agonists Sales Market Share by Application (2016-2026)
Figure 91. Middle East and Africa β Adrenoceptor Agonists Revenue Market Share by Country (2016-2026)
Figure 92. Turkey β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 93. Saudi Arabia β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 94. UAE β Adrenoceptor Agonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 95. Methodology
Figure 96. Research Process and Data Source
世界のβ1アドレナリン受容体作動薬市場 2021：企業別、地域別、種類・用途別 The β1 Adrenoceptor Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界のβ2アドレナリン受容体作動薬市場 2021：企業別、地域別、種類・用途別 The β2 Adrenoceptor Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の非選択的アゴニスト市場 2021：企業別、地域別、種類・用途別 The Nonselective Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の選択的アゴニスト市場 2021：企業別、地域別、種類・用途別 The Selective Agonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- 世界の緑内障点眼薬市場予測（～2024年）：メーカー別、地域別、種類・用途別 Eye drops used in managing glaucoma decrease eye pressure by helping the eye’s fluid to drain better andor decreasing the amount of fluid made by the eye. Scope of the Report: The worldwide market for Glaucoma Eye Drops is expected to grow at a CAGR of roughly xx% over the next five years, will reac…